Immunotherapy – which activates the body's own immune system to kill cancer cells – has not worked well against a rare and ...
Immunotherapy—which activates the body's own immune system to kill cancer cells—has not worked well against a rare and fatal ...
Explore the latest research on rare liver cancer and how a new drug may enable effective immunotherapy treatments.
Global Urology Devices Market OverviewThe global urology devices market is poised for steady expansion and is projected to grow at a CAGR of approximately 6–7% during the forecast period from 2024 to ...
Volvo’s EX60 combines long range, rapid charging, and software-driven design in a way that challenges the remaining rationale for plug-in hybrids and internal combustion engines.
Christina Applegate has revealed a quirky habit that she has that helps when the pain from her multiple sclerosis (MS) flares ...
Teia Collier on MSN
Oncologists urge people to take one common risk factor for cancer seriously
Cancer touches countless lives every year whether through personal diagnosis or the experience of family and friends. According to estimates from the National Cancer Institute more than two million ...
Protara Therapeutics has touted a 66% complete response (CR) rate for its cell therapy among certain bladder cancer patients ...
Dr Parikh explained that KEYNOTE-B15 (NCT04700124) is evaluating the role of perioperative enfortumab vedotin (Padcev), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results